Literature DB >> 23883720

Elizabethkingia meningoseptica: an emerging pathogen causing meningitis in a hospitalized adult trauma patient.

V Tak1, P Mathur, P Varghese, M C Misra.   

Abstract

A 23-year-old male patient who was a follow-up case of neurosurgery presented to our emergency department with a history of high-grade fever and clinical features of meningitis for 1 week. The cerebrospinal fluid (CSF) was sent to our laboratory for culture. The culture demonstrated growth of 1-2 mm in diameter light yellow coloured colonies of Gram-negative bacilli on chocolate and blood agar. There was no growth on MacConkey agar. The bacterium was multidrug resistant. Based upon the growth characteristics, bio-chemical reactions, drug susceptibility pattern and identification by Vitek 2 system the isolate was identified as Elizabethkingia meningoseptica. Patient was treated with injection piperacillin-tazobactam, injection vancomycin and cotrimoxazole tablets for 21 days along with intrathecal injection of tigecycline and finally, patient improved clinically and the CSF cultures became sterile. The presence in hospital environment along with multidrug resistance makes E. meningoseptica a successful emerging nosocomial pathogen.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23883720     DOI: 10.4103/0255-0857.115653

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  7 in total

1.  First report of bacteremia caused by Elizabethkingia meningoseptica in a dog.

Authors:  João Bordelo; Carlos Viegas; Catarina Coelho; Patrícia Poeta
Journal:  Can Vet J       Date:  2016-09       Impact factor: 1.008

2.  Multidrug resistant Elizabethkingia meningoseptica bacteremia - Experience from a level 1 trauma centre in India.

Authors:  Aishwarya Govindaswamy; Vijeta Bajpai; Vivek Trikha; Samarth Mittal; Rajesh Malhotra; Purva Mathur
Journal:  Intractable Rare Dis Res       Date:  2018-08

3.  Intrinsically Resistant Bacteria as Looming Disaster: A Rare Case Report of Elizabethkingia meningoseptica Meningitis in a Neonate.

Authors:  Priyadarshini Patro; Padma Das; Phalguni Padhi
Journal:  J Lab Physicians       Date:  2021-02-22

4.  Evolutionary dynamics and genomic features of the Elizabethkingia anophelis 2015 to 2016 Wisconsin outbreak strain.

Authors:  Amandine Perrin; Elise Larsonneur; Ainsley C Nicholson; David J Edwards; Kristin M Gundlach; Anne M Whitney; Christopher A Gulvik; Melissa E Bell; Olaya Rendueles; Jean Cury; Perrine Hugon; Dominique Clermont; Vincent Enouf; Vladimir Loparev; Phalasy Juieng; Timothy Monson; David Warshauer; Lina I Elbadawi; Maroya Spalding Walters; Matthew B Crist; Judith Noble-Wang; Gwen Borlaug; Eduardo P C Rocha; Alexis Criscuolo; Marie Touchon; Jeffrey P Davis; Kathryn E Holt; John R McQuiston; Sylvain Brisse
Journal:  Nat Commun       Date:  2017-05-24       Impact factor: 14.919

5.  Candidate Animal Disease Model of Elizabethkingia Spp. Infection in Humans, Based on the Systematic Pathology and Oxidative Damage Caused by E. miricola in Pelophylax nigromaculatus.

Authors:  Xiaoli Huang; Yang Feng; Hong Tang; Guanqing Xiong; Liangyu Li; Yucen Yang; Kaiyu Wang; Ping Ouyang; Yi Geng; Defang Chen; Shiyong Yang
Journal:  Oxid Med Cell Longev       Date:  2019-09-18       Impact factor: 6.543

6.  Risk Factors for Mortality in Patients with Elizabethkingia Infection and the Clinical Impact of the Antimicrobial Susceptibility Patterns of Elizabethkingia Species.

Authors:  Hye Seong; Jung Ho Kim; Jun Hyoung Kim; Woon Ji Lee; Jin Young Ahn; Nam Su Ku M D; Jun Yong Choi; Joon Sup Yeom; Young Goo Song; Su Jin Jeong
Journal:  J Clin Med       Date:  2020-05-12       Impact factor: 4.241

7.  Nosocomial Elizabethkingia meningoseptica meningitis and bacteremia in a post transsphenoidal hypophysectomy complicated with sagittal sinus thrombosis: A case report.

Authors:  Naavin Kumar Balakrishnan; Abdul Rahman Izaini Ghani; Mohamad Hasyizan Hassan; Laila Ab Mukmin; W Mohd Nazaruddin W Hassan
Journal:  Surg Neurol Int       Date:  2022-08-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.